Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
$2.12
CAD
+0.01 (0.47%)
Last updated: 2026-08-12
Get CRDL alerts:
CRDL
Cardiol Therapeutics Inc Class A
WealthAwesomePerformance
1 Day
+0.47%
1 Week
+11.58%
1 Month
+41.33%
YTD
+55.88%
Key Statistics
Market Cap
$243.22M
52W High
$2.33
52W Low
$1.23
P/E Ratio
-
50 Day MA
$1.62
200 Day MA
$1.57
Beta
0.47
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/12/2026 | $2.10 | $2.12 | $2.00 | $2.12 | $2.12 | 236,800 |
| 8/11/2026 | $2.07 | $2.12 | $2.02 | $2.11 | $2.11 | 151,752 |
| 8/10/2026 | $1.99 | $2.09 | $1.93 | $2.06 | $2.06 | 264,754 |
| 8/7/2026 | $1.91 | $1.99 | $1.89 | $1.99 | $1.99 | 127,972 |
| 8/6/2026 | $1.88 | $1.94 | $1.85 | $1.93 | $1.93 | 130,571 |
| 8/5/2026 | $1.91 | $1.92 | $1.85 | $1.90 | $1.90 | 117,281 |
| 8/4/2026 | $1.80 | $1.92 | $1.80 | $1.92 | $1.92 | 197,327 |
| 7/31/2026 | $1.72 | $1.80 | $1.70 | $1.76 | $1.76 | 153,900 |
| 7/30/2026 | $1.65 | $1.73 | $1.61 | $1.71 | $1.71 | 138,783 |
| 7/29/2026 | $1.68 | $1.70 | $1.61 | $1.63 | $1.63 | 89,426 |
Analyst Price Targets
Based on analyst covering CRDL
Wall Street analysts forecast CRDL stock price to rise 183.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+183.0% Upside
Current Price
C$2.12
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
60.5%
Annualized
90-Day Vol
55.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.53
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.25 | C$1.83 – C$2.77 |
| 60 trading days | C$2.39 | C$1.78 – C$3.21 |
| 90 trading days | C$2.53 | C$1.77 – C$3.64 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.57M
- Profit Margin
- 0.00%
- ROE (TTM)
- -173.96%
- EPS (Diluted)
- -0.39
- Book Value
- 0.22
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
CRDL.TO news timeline
15 articles covering CRDL.TO, most recent first
LatestWhy Cardiol Therapeutics Inc Class A stock is sliding today
August 2026
July 2026
- Why Cardiol Therapeutics Inc Class A stock is rising today
- Top penny stocks on the TSX & TSXV — July 31, 2026
- Top penny stocks on the TSX & TSXV — July 30, 2026
- Top penny stocks on the TSX & TSXV — July 28, 2026
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Top penny stocks on the TSX & TSXV — July 27, 2026
- Why Cardiol Therapeutics Inc Class A stock is sliding today
- What's Going On With Cardiol Therapeutics Inc Class A Stock Monday?
- Why Cardiol Therapeutics Inc Class A stock is sliding today
- Why Cardiol Therapeutics Inc Class A stock is skyrocketing today